US on Positive Trajectory, though COVID Variant Emergence Continues
Key Points: COVID In today’s Recommendation for Industry, we discuss the overall positive trajectory of COVID cases, even with variants continuing to emerge. Read more
Key Points: COVID In today’s Recommendation for Industry, we discuss the overall positive trajectory of COVID cases, even with variants continuing to emerge. Read more
Key Points: COVID In today’s Recommendation for Industry, we discuss norovirus cases. Read more below. Updated COVID booster tied to strong Omicron immune response. The
Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read
Key Points: In today’s Recommendation for Industry, we discuss how cases seem to be improving and moving across the country, as shown through the CDC
Key Points: In today’s Recommendations for Industry, we discuss COVID-19 trends stabilizing and declining. Read more below. The CDC released research done on post-COVID conditions
Key Points: In today’s Recommendations for Industry, we discuss COVID-19 variants, BA.4 and BA.5. Read more below. Despite what many of us might like to
Key Points: In today’s Recommendations for Industry, we discuss the trends of COVID based on TAG’s weekly matrix and the CDC community levels mapping. Read
Key Points: In today’s Recommendations for Industry, we discuss the latest COVID transmissibility data from both TAG’s matrix and CDC’s mapping. Read more below. Today,
Key Points: In today’s Recommendations for Industry, we discuss the continuing evolution of COVID variants and what this means for your business. Read more below.
Key Points: In today’s Recommendations for Industry, we discuss the slight increase in cases around the U.S. Read more below. The FDA is warning consumers
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.